Medico Intercontinental Limited (BOM:539938)
25.50
+0.65 (2.62%)
At close: Sep 11, 2026
Medico Intercontinental Revenue
Medico Intercontinental had revenue of 208.45M INR in the quarter ending June 30, 2026, a decrease of -3.58%. This brings the company's revenue in the last twelve months to 838.36M, down -14.97% year-over-year. In the fiscal year ending March 31, 2026, Medico Intercontinental had annual revenue of 846.09M, down -11.53%.
Revenue (ttm)
838.36M
Revenue Growth
-14.97%
P/S Ratio
0.30
Revenue / Employee
22.06M
Employees
38
Market Cap
255.00M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 846.09M | -110.28M | -11.53% |
| Mar 31, 2025 | 956.37M | 241.30M | 33.74% |
| Mar 31, 2024 | 715.07M | -50.15M | -6.55% |
| Mar 31, 2023 | 765.22M | 21.42M | 2.88% |
| Mar 31, 2022 | 743.80M | 46.10M | 6.61% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Centuple Global | 5.62B |
| Dipna Pharmachem | 1.29B |
| Chandra Bhagat Pharma | 1.17B |
| Medistep Healthcare | 708.31M |
| Zenlabs Ethica | 496.22M |
| Constronics Infra | 454.43M |
| Goldline Pharmaceutical | 311.98M |
| Muller & Phipps (India) | 67.05M |